The role of L-ornithine-L-aspartate in the management of minimal hepatic encephalopathy among patients with liver cirrhosis: A systemic review and meta-analysis
Oral L-ornithine-L-aspartate for patients with overt hepatic encephalopathy treated with lactulose: A randomized, double-blinded, placebo-controlled trial